Drug Discovery and Development Based on Quantitative Systems Pharmacology (QSP)

Drug Discovery and Development Based on Quantitative Systems Pharmacology (QSP)

  • Home
  • About UPDDI
    • Programs
      • Liver Diseases
      • Metastatic Cancer
      • Neurodegenerative Diseases
    • Projects
      • Drugs Against SARS-CoV-2
      • Triose phosphate Isomerase deficiency
      • Tissue Chip Testing Center
      • Acute Kidney Injury
      • Mcm2-7 Replicative Helicase
      • Autosomal Dominant Leukodystrophy
      • MAP Kinase Phosphatases
      • Malignant Gliomas
    • Technical Strengths
      • Discovery Technologies
      • Chemistry/Medicinal Chemistry
      • Early Safety Assessment
      • Computational Chemistry
      • Computational Biology
      • Preclinical ADME/Tox & Rodent Efficacy
    • Collaborations
  • Environment
    • Drug Discovery Education
    • Facilities
      • Discovery Technology
      • Chemistry/Medicinal Chemistry
      • Computational Biology & Chemistry
      • Zebrafish Facility
      • Preclinical Resources
  • People
    • Director/Associate Directors
    • Internal Advisory Board
    • External Advisory Board
    • Leadership Faculty
    • Core Faculty
    • Team Members
  • News + Events
    • News
    • Events
  • Publications
  • BioSystics-AP (formerly MPS-Db)
  • Contact Us
    • Positions Available
    • Giving
MENUMENU
  • Home
  • About UPDDI
    • Programs
      • Liver Diseases
      • Metastatic Cancer
      • Neurodegenerative Diseases
    • Projects
      • Drugs Against SARS-CoV-2
      • Triose phosphate Isomerase deficiency
      • Tissue Chip Testing Center
      • Acute Kidney Injury
      • Mcm2-7 Replicative Helicase
      • Autosomal Dominant Leukodystrophy
      • MAP Kinase Phosphatases
      • Malignant Gliomas
    • Technical Strengths
      • Discovery Technologies
      • Chemistry/Medicinal Chemistry
      • Early Safety Assessment
      • Computational Chemistry
      • Computational Biology
      • Preclinical ADME/Tox & Rodent Efficacy
    • Collaborations
  • Environment
    • Drug Discovery Education
    • Facilities
      • Discovery Technology
      • Chemistry/Medicinal Chemistry
      • Computational Biology & Chemistry
      • Zebrafish Facility
      • Preclinical Resources
  • People
    • Director/Associate Directors
    • Internal Advisory Board
    • External Advisory Board
    • Leadership Faculty
    • Core Faculty
    • Team Members
  • News + Events
    • News
    • Events
  • Publications
  • BioSystics-AP (formerly MPS-Db)
  • Contact Us
    • Positions Available
    • Giving

Programs

Liver Diseases

Metastatic Cancers

Neurodegenerative Diseases

Copyright © 2023 University of Pittsburgh Drug Discovery Institute

WordPress Image Lightbox Plugin